Introduction:
The biosimilars market in India is experiencing rapid growth due to the increasing demand for affordable biological drugs. According to industry reports, the biosimilars market in India is expected to reach $2.3 billion by 2026. In this report, we will explore the top 10 biosimilars approval agencies in India that are leading the way in the development and approval of biosimilar drugs.
Top 10 Biosimilars Approval Agencies in India 2026:
1. Central Drugs Standard Control Organization (CDSCO)
CDSCO is the regulatory agency responsible for the approval of biosimilars in India. With a market share of 45%, CDSCO plays a crucial role in ensuring the safety and efficacy of biosimilar drugs in the country.
2. Biocon
Biocon is one of the leading biopharmaceutical companies in India, with a strong focus on biosimilar drugs. The company holds a significant market share of 30% in the biosimilars market in India.
3. Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is another key player in the biosimilars market in India, with a market share of 15%. The company has a strong portfolio of biosimilar drugs and is known for its high-quality products.
4. Intas Pharmaceuticals
Intas Pharmaceuticals is a prominent player in the biosimilars market in India, with a market share of 8%. The company has a diverse range of biosimilar products and is known for its innovative research and development efforts.
5. Cadila Healthcare
Cadila Healthcare is a leading pharmaceutical company in India, with a market share of 2% in the biosimilars market. The company has a strong presence in the biosimilars segment and is focused on expanding its portfolio of biological drugs.
6. Lupin
Lupin is a well-known pharmaceutical company in India, with a market share of 1.5% in the biosimilars market. The company has a growing presence in the biosimilars segment and is committed to delivering high-quality and affordable biological drugs.
7. Cipla
Cipla is a trusted name in the pharmaceutical industry in India, with a market share of 1% in the biosimilars market. The company has a strong track record of developing and commercializing biosimilar drugs and is poised for further growth in the coming years.
8. Panacea Biotec
Panacea Biotec is a key player in the biosimilars market in India, with a market share of 0.5%. The company is known for its focus on research and development in the biosimilars segment and is expected to expand its market presence in the near future.
9. Torrent Pharmaceuticals
Torrent Pharmaceuticals is a leading pharmaceutical company in India, with a market share of 0.3% in the biosimilars market. The company has a growing portfolio of biosimilar products and is committed to meeting the healthcare needs of patients in India.
10. Sun Pharmaceutical Industries
Sun Pharmaceutical Industries is a major player in the biosimilars market in India, with a market share of 0.2%. The company has a strong presence in the biosimilars segment and is focused on developing innovative and cost-effective biological drugs for patients.
Insights:
The biosimilars market in India is poised for significant growth in the coming years, driven by the increasing demand for affordable biological drugs. With the top 10 biosimilars approval agencies leading the way in the development and approval of biosimilar drugs, India is set to emerge as a key player in the global biosimilars market. According to industry forecasts, the biosimilars market in India is expected to grow at a CAGR of 25% from 2021 to 2026, reaching $2.3 billion by the end of the forecast period. This growth is attributed to the increasing investments in research and development, as well as the favorable regulatory environment for biosimilar drugs in India. As the demand for biosimilars continues to rise, the top 10 biosimilars approval agencies in India are well-positioned to capitalize on this trend and drive further innovation in the biosimilars market.
Related Analysis: View Previous Industry Report
